Amundi Asset Management US’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $4.14M | Buy |
+136,000
| New | +$4.14M | ﹤0.01% | 1051 |
|
|
2020
Q2 | – | Sell |
-7,000
| Closed | -$100K | – | 1639 |
|
|
2020
Q1 | $100K | Hold |
7,000
| – | – | ﹤0.01% | 1421 |
|
|
2019
Q4 | $191K | Hold |
7,000
| – | – | ﹤0.01% | 1468 |
|
|
2019
Q3 | $200K | Buy |
7,000
+1,500
| +27% | +$42.9K | ﹤0.01% | 1439 |
|
|
2019
Q2 | $153K | Hold |
5,500
| – | – | ﹤0.01% | 1488 |
|
|
2019
Q1 | $183K | Buy |
+5,500
| New | +$183K | ﹤0.01% | 1427 |
|
|
2018
Q4 | – | Sell |
-15,400
| Closed | -$708K | – | 1623 |
|
|
2018
Q3 | $708K | Buy |
+15,400
| New | +$708K | ﹤0.01% | 1274 |
|